Pyroptosis of Vascular Smooth Muscle Cells as a Potential New Target for Preventing Vascular Diseases
- PMID: 38822974
- DOI: 10.1007/s10557-024-07578-w
Pyroptosis of Vascular Smooth Muscle Cells as a Potential New Target for Preventing Vascular Diseases
Abstract
Vascular remodeling is the adaptive response of the vessel wall to physiological and pathophysiological changes, closely linked to vascular diseases. Vascular smooth muscle cells (VSMCs) play a crucial role in this process. Pyroptosis, a form of programmed cell death characterized by excessive release of inflammatory factors, can cause phenotypic transformation of VSMCs, leading to their proliferation, migration, and calcification-all of which accelerate vascular remodeling. Inhibition of VSMC pyroptosis can delay this process. This review summarizes the impact of pyroptosis on VSMCs and the pathogenic role of VSMC pyroptosis in vascular remodeling. We also discuss inhibitors of key proteins in pyroptosis pathways and their effects on VSMC pyroptosis. These findings enhance our understanding of the pathogenesis of vascular remodeling and provide a foundation for the development of novel medications that target the control of VSMC pyroptosis as a potential treatment strategy for vascular diseases.
Keywords: Pyroptosis; VSMC; Vascular diseases; Vascular remodeling.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease.Cell Death Dis. 2022 Mar 30;13(3):283. doi: 10.1038/s41419-022-04735-7. Cell Death Dis. 2022. PMID: 35354793 Free PMC article.
-
Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling.Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2154-2168. doi: 10.1016/j.bbadis.2018.04.002. Epub 2018 Apr 5. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29627363
-
Effect of tissue factor pathway inhibitor on the pyroptosis of vascular smooth muscle cells induced by angiotensin II.Cardiovasc Diagn Ther. 2024 Feb 15;14(1):72-83. doi: 10.21037/cdt-23-355. Epub 2024 Jan 19. Cardiovasc Diagn Ther. 2024. PMID: 38434568 Free PMC article.
-
MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling.Cell Mol Life Sci. 2023 May 10;80(6):144. doi: 10.1007/s00018-023-04793-w. Cell Mol Life Sci. 2023. PMID: 37165163 Free PMC article. Review.
-
Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity.Cell Signal. 2018 Dec;52:48-64. doi: 10.1016/j.cellsig.2018.08.019. Epub 2018 Aug 30. Cell Signal. 2018. PMID: 30172025 Review.
Cited by
-
Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis.Mol Biol Rep. 2025 May 15;52(1):459. doi: 10.1007/s11033-025-10554-8. Mol Biol Rep. 2025. PMID: 40372511 Review.
-
ALOX5 regulates vascular smooth muscle cells pyroptosis to affect abdominal aortic aneurysm formation.Sci Rep. 2025 Aug 9;15(1):29123. doi: 10.1038/s41598-025-14268-6. Sci Rep. 2025. PMID: 40781109 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources